[144] Esperion Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Esperion Therapeutics (ESPR) Form 144 notice: The filer reports a proposed sale of 6,267 common shares with an aggregate market value of $17,575.80, to be sold through Fidelity Brokerage Services LLC on or about 09/17/2025 on the NASDAQ. The shares were acquired on 09/15/2025 by restricted stock vesting from the issuer and were paid as compensation. The filing also discloses sales by the same person in the prior three months: 6,422 shares sold on 06/17/2025 for $7,397.50 and 1,304 shares sold on 07/17/2025 for $1,469.35. The notice includes the standard representation that the seller is unaware of any undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6267	17575.80	201622825	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Vesting	Issuer			6267	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Looker 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	06/17/2025	6422	7397.50
Benjamin Looker 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	07/17/2025	1304	1469.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Esperion (ESPR) Form 144 disclose?

The notice discloses a proposed sale of 6,267 common shares (aggregate market value $17,575.80) to be sold via Fidelity on or about 09/17/2025.

How were the 6,267 ESPR shares acquired?

The shares were acquired on 09/15/2025 through restricted stock vesting from the issuer and the consideration is listed as compensation.

Were there any recent ESPR share sales by the same person?

Yes. The filer reported selling 6,422 shares on 06/17/2025 for $7,397.50 and 1,304 shares on 07/17/2025 for $1,469.35.

Through which broker will the ESPR shares be sold?

The broker listed is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI, and the exchange is the NASDAQ.

Does the filing state any undisclosed material information about Esperion?

The seller represents by signature that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.